During the last session, Bristol-Myers Squibb Co (NYSE:BMY)’s traded shares were 12.42 million, with the beta value of the company hitting 0.37. At the end of the trading day, the stock’s price was $46.97, reflecting an intraday gain of 0.17% or $0.08. The 52-week high for the BMY share is $63.33, that puts it down -34.83 from that peak though still a striking 16.22% gain since the share price plummeted to a 52-week low of $39.35. The company’s market capitalization is $95.59B, and the average trade volume was 14.95 million shares over the past three months.
Bristol-Myers Squibb Co (BMY) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 2.64. BMY has a Sell rating from 0 analyst(s) out of 14 analysts who have looked at this stock. 9 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 5 recommend a Buy rating for it.
Bristol-Myers Squibb Co (NYSE:BMY) trade information
Bristol-Myers Squibb Co (BMY) registered a 0.17% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.17% in intraday trading to $46.97, hitting a weekly high. The stock’s 5-day price performance is -1.88%, and it has moved by -3.07% in 30 days. Based on these gigs, the overall price performance for the year is 13.07%.
The consensus price target of analysts on Wall Street is $66.5, which implies an increase of 29.37% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $65 and $68 respectively. As a result, BMY is trading at a discount of -44.77% off the target high and -38.39% off the low.
BMY Dividends
Bristol-Myers Squibb Co is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Bristol-Myers Squibb Co is 2.44, with the dividend yield indicating at 5.19 percent, continuing the trend of increasing dividends in recent years.
Bristol-Myers Squibb Co (NYSE:BMY)’s Major holders
The next largest institutional holding, with 158.66 million shares, is of BLACKROCK INC.’s that is approximately 7.8273% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $6.59 billion.
Also, the Mutual Funds coming in first place with the largest holdings of Bristol-Myers Squibb Co (BMY) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund. Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 63.59 shares. This amounts to just over 3.12 percent of the company’s overall shares, with a $2.99 billion market value. The same data shows that the other fund manager holds slightly less at 54.9, or about 2.70% of the stock, which is worth about $2.58 billion.
